164 related articles for article (PubMed ID: 34750461)
1. Enzymatic ligation of an antibody and arginine 9 peptide for efficient and cell-specific siRNA delivery.
Ando Y; Nakazawa H; Miura D; Otake M; Umetsu M
Sci Rep; 2021 Nov; 11(1):21882. PubMed ID: 34750461
[TBL] [Abstract][Full Text] [Related]
2. Nanobody-siRNA Conjugates for Targeted Delivery of siRNA to Cancer Cells.
Zavoiura O; Brunner B; Casteels P; Zimmermann L; Ozog M; Boutton C; Helms MW; Wagenaar T; Adam V; Peterka J; Metz-Weidmann C; Deschaght P; Scheidler S; Jahn-Hofmann K
Mol Pharm; 2021 Mar; 18(3):1048-1060. PubMed ID: 33444501
[TBL] [Abstract][Full Text] [Related]
3. Physicochemical characterization of siRNA-peptide complexes.
Law M; Jafari M; Chen P
Biotechnol Prog; 2008; 24(4):957-63. PubMed ID: 19194904
[TBL] [Abstract][Full Text] [Related]
4. A novel silk fibroin protein-based fusion system for enhancing the expression of nanobodies in Escherichia coli.
Yu J; Guo Y; Gu Y; Fan X; Li F; Song H; Nian R; Liu W
Appl Microbiol Biotechnol; 2022 Mar; 106(5-6):1967-1977. PubMed ID: 35243528
[TBL] [Abstract][Full Text] [Related]
5. Cell-penetrable nanobodies (transbodies) that inhibit the tyrosine kinase activity of EGFR leading to the impediment of human lung adenocarcinoma cell motility and survival.
Tabtimmai L; Suphakun P; Srisook P; Kiriwan D; Phanthong S; Kiatwuthinon P; Chaicumpa W; Choowongkomon K
J Cell Biochem; 2019 Oct; 120(10):18077-18087. PubMed ID: 31172597
[TBL] [Abstract][Full Text] [Related]
6. Comparative analysis of fusion tags used to functionalize recombinant antibodies.
Veggiani G; Giabbai B; Semrau MS; Medagli B; Riccio V; Bajc G; Storici P; de Marco A
Protein Expr Purif; 2020 Feb; 166():105505. PubMed ID: 31563543
[TBL] [Abstract][Full Text] [Related]
7. Production of a mono-biotinylated EGFR nanobody in the E. coli periplasm using the pET22b vector.
Noor A; Walser G; Wesseling M; Giron P; Laffra AM; Haddouchi F; De Grève J; Kronenberger P
BMC Res Notes; 2018 Oct; 11(1):751. PubMed ID: 30348204
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of HIV replication through siRNA carried by CXCR4-targeted chimeric nanobody.
Cunha-Santos C; Perdigao PRL; Martin F; Oliveira JG; Cardoso M; Manuel A; Taveira N; Goncalves J
Cell Mol Life Sci; 2020 Jul; 77(14):2859-2870. PubMed ID: 31641784
[TBL] [Abstract][Full Text] [Related]
9. An efficient protocol towards site-specifically clickable nanobodies in high yield: cytoplasmic expression in Escherichia coli combined with intein-mediated protein ligation.
Ta DT; Redeker ES; Billen B; Reekmans G; Sikulu J; Noben JP; Guedens W; Adriaensens P
Protein Eng Des Sel; 2015 Oct; 28(10):351-63. PubMed ID: 26243885
[TBL] [Abstract][Full Text] [Related]
10. Peptides in headlock--a novel high-affinity and versatile peptide-binding nanobody for proteomics and microscopy.
Braun MB; Traenkle B; Koch PA; Emele F; Weiss F; Poetz O; Stehle T; Rothbauer U
Sci Rep; 2016 Jan; 6():19211. PubMed ID: 26791954
[TBL] [Abstract][Full Text] [Related]
11. Recombinant phosphatidylserine-binding nanobodies for targeting of extracellular vesicles to tumor cells: a plug-and-play approach.
Kooijmans SAA; Gitz-Francois JJJM; Schiffelers RM; Vader P
Nanoscale; 2018 Feb; 10(5):2413-2426. PubMed ID: 29334397
[TBL] [Abstract][Full Text] [Related]
12. Characterization and comparison of two peptide-tag specific nanobodies for immunoaffinity chromatography.
Ren J; Zhang C; Ji F; Jia L
J Chromatogr A; 2020 Aug; 1624():461227. PubMed ID: 32540069
[TBL] [Abstract][Full Text] [Related]
13. Nanobody click chemistry for convenient site-specific fluorescent labelling, single step immunocytochemistry and delivery into living cells by photoporation and live cell imaging.
Hebbrecht T; Liu J; Zwaenepoel O; Boddin G; Van Leene C; Decoene K; Madder A; Braeckmans K; Gettemans J
N Biotechnol; 2020 Nov; 59():33-43. PubMed ID: 32659511
[TBL] [Abstract][Full Text] [Related]
14. Direct Immobilization of Engineered Nanobodies on Gold Sensors.
Simões B; Guedens WJ; Keene C; Kubiak-Ossowska K; Mulheran P; Kotowska AM; Scurr DJ; Alexander MR; Broisat A; Johnson S; Muyldermans S; Devoogdt N; Adriaensens P; Mendes PM
ACS Appl Mater Interfaces; 2021 Apr; 13(15):17353-17360. PubMed ID: 33845569
[TBL] [Abstract][Full Text] [Related]
15. Enzymatic functionalization of a nanobody using protein insertion technology.
Crasson O; Rhazi N; Jacquin O; Freichels A; Jérôme C; Ruth N; Galleni M; Filée P; Vandevenne M
Protein Eng Des Sel; 2015 Oct; 28(10):451-60. PubMed ID: 25852149
[TBL] [Abstract][Full Text] [Related]
16. Poly-L-arginine and dextran sulfate-based nanocomplex for epidermal growth factor receptor (EGFR) siRNA delivery: its application for head and neck cancer treatment.
Cho HJ; Chong S; Chung SJ; Shim CK; Kim DD
Pharm Res; 2012 Apr; 29(4):1007-19. PubMed ID: 22169985
[TBL] [Abstract][Full Text] [Related]
17. Matrix metalloproteinase 2-responsive micelle for siRNA delivery.
Wang HX; Yang XZ; Sun CY; Mao CQ; Zhu YH; Wang J
Biomaterials; 2014 Aug; 35(26):7622-34. PubMed ID: 24929619
[TBL] [Abstract][Full Text] [Related]
18. A designed recombinant fusion protein for targeted delivery of siRNA to the mouse brain.
Haroon MM; Dar GH; Jeyalakshmi D; Venkatraman U; Saba K; Rangaraj N; Patel AB; Gopal V
J Control Release; 2016 Apr; 228():120-131. PubMed ID: 26948382
[TBL] [Abstract][Full Text] [Related]
19. Construction and Biological Evaluation of a Novel Integrin α
Chen X; Liu M; Wang R; Yan P; Zhang C; Ma C; Yin L
Molecules; 2017 Feb; 22(2):. PubMed ID: 28165399
[TBL] [Abstract][Full Text] [Related]
20. Design and evaluation of histidine-rich amphipathic peptides for siRNA delivery.
Langlet-Bertin B; Leborgne C; Scherman D; Bechinger B; Mason AJ; Kichler A
Pharm Res; 2010 Jul; 27(7):1426-36. PubMed ID: 20393870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
